AbbVie Stock Jumped Today: Deal Sparks New Outlook for Investors
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Use consistent tracking methods, categorize every expense, and summarize weekly to maintain tight control of monthly spending.
19,095 articlesAbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Dividend investors face a crowded field. This article compares Pfizer and Verizon Communications to answer pfizer ver...
When a top executive sells a large block, investors want to know what it really signals. This analysis breaks down th...
Meme coins surged with viral fame, but a political push to bar elected officials from launching them could reshape th...
Jaguar Land Rover is recalling roughly 2,300 US-registered I-Pace electric SUVs due to a high-voltage battery fire ri...
A new AI-driven marketing platform is raising Reg A+ funds at $0.85 per share, pitching a fast-growth TMT play for in...
A bold stake in a boutique asset-manager platform is sending ripples through the investing world. This article explai...
Dive into veeva (veev) 2026 earnings with a close look at Q4 results, guidance, and what the numbers mean for investo...
A tough week tested my discipline as markets swung wildly. I trimmed a few positions and redirected cash to stronger ...
ClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...
A wave of autonomous AI agents is entering consumer finance, promising smarter budgeting and investing. Yet reliabili...
When a space company announces a bold acquisition, investors sit up. This article breaks down what york space buys al...